BIOA · BioAge Labs Inc
United States · RS rating 6 · As of 2026-10-14
| Price | 5.42 USD |
|---|---|
| 1-day change | -2.7% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 5 / 2 / 43 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 16 / 16 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | -11.5% |
| Sales growth Q/Q | +49.9% |
| Distance from 52-week high | +78.4% |
| Market cap (USD) | $765.4M |